Literature DB >> 22001470

Erythroid crisis caused by parvovirus B19 transmitted via red blood cell transfusion.

Yuiko Tsukada1, Kenji Yokoyama, Akaru Ishida, Makoto Handa, Takehiko Mori, Masahiro Kizaki, Shinichiro Okamoto.   

Abstract

A 41-year-old man with hairy cell leukemia developed erythroid crisis after the transfusion of red cell concentrate. He was diagnosed with Parvovirus B19 infection based upon the presence of B19-specific IgM antibody and viral DNA in the sera. The repository sample from the corresponding red cell concentrate was negative for B19 antigen by red cell hemo-agglutination method, but was found to contain B19 virus DNA. Furthermore, a genomic PCR direct sequencing showed that B19 in both patient's sera and repository sample were identical. This is the first report directly demonstrating the transmission of B19 through B19 antigen-negative red cell concentrate transfusion. Further accumulation of the cases is warranted to estimate its incidence and to reconsider the screening methods of blood products.

Entities:  

Mesh:

Year:  2011        PMID: 22001470     DOI: 10.2169/internalmedicine.50.5458

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

1.  The effects of co-infection with human parvovirus B19 and Plasmodium falciparum on type and degree of anaemia in Ghanaian children.

Authors:  Kwabena Obeng Duedu; Kwamena William Coleman Sagoe; Patrick Ferdinand Ayeh-Kumi; Raymond Bedu Affrim; Theophilus Adiku
Journal:  Asian Pac J Trop Biomed       Date:  2013-02

2.  Existence of various human parvovirus B19 genotypes in Chinese plasma pools: genotype 1, genotype 3, putative intergenotypic recombinant variants and new genotypes.

Authors:  Junting Jia; Yuyuan Ma; Xiong Zhao; Chaoji Huangfu; Yadi Zhong; Chi Fang; Rui Fan; Maomin Lv; Jingang Zhang
Journal:  Virol J       Date:  2016-09-17       Impact factor: 4.099

Review 3.  Current concepts in the prevention of pathogen transmission via blood/plasma-derived products for bleeding disorders.

Authors:  Giovanni Di Minno; Carlo Federico Perno; Andreas Tiede; David Navarro; Mariana Canaro; Lutz Güertler; James W Ironside
Journal:  Blood Rev       Date:  2015-07-20       Impact factor: 8.250

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.